Amh Equity LTD Harvard Bioscience Inc Put Options Transaction History
Amh Equity LTD
- $72.3 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HBIO
# of Institutions
89Shares Held
25.8MCall Options Held
8.7KPut Options Held
2K-
Black Rock Inc. New York, NY2.84MShares$1.31 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.19MShares$1.01 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$983,8240.0% of portfolio
-
Royce & Associates LP1.78MShares$817,8310.01% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.53MShares$702,8310.05% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $19.2M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...